1 |
(18)f-fdg |
- |
- |
- |
- |
085 [1] 85 💬 |
2 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 [12] 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
3 |
3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(n-butyloxylcarbamate)-sulphonamide] sodium salt |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
4 |
534-1508 |
- |
- |
- |
- |
085 [1] 85 💬 |
5 |
68ga-bmv101 |
- |
- |
- |
- |
085 [1] 85 💬 |
6 |
[18f]-fba-a20fmdv2 |
- |
- |
- |
- |
085 [1] 85 💬 |
7 |
[18f]fp-r01-mg-f2 |
- |
- |
- |
- |
085 [2] 85, 94 💬 |
8 |
[68ga]cbp8 |
- |
- |
- |
- |
085 [1] 85 💬 |
9 |
[bg00011] |
- |
- |
- |
- |
085 [1] 85 💬 |
10 |
[rvt-1601 (in precedenza pa101b)] |
- |
- |
- |
- |
085 [1] 85 💬 |
11 |
Acetate |
Acetate |
- |
- |
- |
001 [43] 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
12 |
Acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [16] 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
13 |
Acetylcysteine effervescent tablets |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
085 [1] 85 💬 |
14 |
Act-064992 |
- |
- |
- |
- |
051 [5] 51, 85, 86, 88, 210 💬 |
15 |
Act-064992 (macitentan) |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
16 |
Adult human mesenchymal stem cells |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
085 [2] 85, 96 💬 |
17 |
Aerosol interferon-gamma |
- |
- |
- |
- |
085 [1] 85 💬 |
18 |
Air |
- |
- |
- |
- |
003 [7] 3 , 51, 58, 85, 97, 193, 299 💬 |
19 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
20 |
Allogeneic adult human mesenchymal stem cells (hmscs) |
Remestemcel-L |
[1] D09719 D09719 💬 |
- |
- |
085 [1] 85 💬 |
21 |
Ambrisentan |
Ambrisentan |
[1] D07077 D07077 💬 |
EDNRA [1] EDNRA 💬 |
Calcium signaling pathway [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [7] 51, 84, 85, 86, 88, 210, 211 💬 |
22 |
Antimicrobial therapy: co-trimoxazole or doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
085 [1] 85 💬 |
23 |
Art-123 |
- |
- |
- |
- |
085 [1] 85 💬 |
24 |
Atezolizumab |
Atezolizumab |
[1] D10773 D10773 💬 |
CD274 [1] CD274 💬 |
Cell adhesion molecules [2] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer |
085 [1] 85 💬 |
25 |
Autoantibody reductive therapy |
- |
- |
- |
- |
085 [1] 85 💬 |
26 |
Autologous adipose derived mscs (admscs) |
- |
- |
- |
- |
085 [1] 85 💬 |
27 |
Autologous mesenchymal stem cells derived from bone marrow |
- |
- |
- |
- |
085 [1] 85 💬 |
28 |
Autologous stromal vascular fraction (svf) |
- |
- |
- |
- |
085 [1] 85 💬 |
29 |
Aviptadil |
Aviptadil |
- |
- |
- |
049 [4] 49, 51, 85, 86 💬 |
30 |
Aviptadil, 66 microgram/ml |
Aviptadil |
- |
- |
- |
085 [1] 85 💬 |
31 |
Azapred |
- |
- |
- |
- |
085 [1] 85 💬 |
32 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
33 |
Azathioprine/prednisone |
Azathioprine |
[3] D00238 D00238, D00473 D00473, D03033 D03033 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
34 |
Azithromycin |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 [6] 13, 84, 85, 96, 228, 299 💬 |
35 |
Bardoxolone |
Bardoxolone |
[1] D09584 D09584 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
36 |
Bardoxolone methyl |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
37 |
Bbt-877, multiple doses |
- |
- |
- |
- |
085 [1] 85 💬 |
38 |
Bbt-877, single dose |
- |
- |
- |
- |
085 [1] 85 💬 |
39 |
Beclometasone dipropionate |
Beclomethasone dipropionate |
[2] D00689 D00689, D07495 D07495 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [2] 85, 97 💬 |
40 |
Bevacizumab |
Bevacizumab |
[1] D06409 D06409 💬 |
VEGFA [1] VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 [9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
41 |
Bg00011 |
- |
- |
- |
- |
085 [1] 85 💬 |
42 |
Bi 1015550 |
- |
- |
- |
- |
085 [1] 85 💬 |
43 |
Bibf 1120 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
44 |
Bibf 1120 es |
- |
- |
- |
- |
085 [1] 85 💬 |
45 |
Bibf1120 |
- |
- |
- |
- |
085 [1] 85 💬 |
46 |
Bld-2660 |
- |
- |
- |
- |
085 [1] 85 💬 |
47 |
Blood sample collection |
- |
- |
- |
- |
085 [1] 85 💬 |
48 |
Bms-986020 |
BMS-986020 |
- |
- |
- |
051 [2] 51, 85 💬 |
49 |
Bms-986278 |
- |
- |
- |
- |
085 [1] 85 💬 |
50 |
Bone marrow mesenchymal stem cells |
- |
- |
- |
- |
085 [1] 85 💬 |
51 |
Bosentan |
Bosentan |
[2] D01227 D01227, D07538 D07538 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [11] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
52 |
C21 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
53 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
54 |
Carbon monoxide |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
085 [3] 85, 86, 298 💬 |
55 |
Carboplatin |
Carboplatin |
[1] D01363 D01363 💬 |
- |
- |
028 [4] 28, 34, 60, 85 💬 |
56 |
Caveolin-1-scaffolding-protein-derived peptide (lti-03) |
- |
- |
- |
- |
085 [1] 85 💬 |
57 |
Cbdca |
Carboplatin |
[1] D01363 D01363 💬 |
- |
- |
085 [1] 85 💬 |
58 |
Cc |
- |
- |
- |
- |
013 [13] 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
59 |
Cc-90001 |
- |
- |
- |
- |
085 [1] 85 💬 |
60 |
Cc-930 |
- |
- |
- |
- |
085 [1] 85 💬 |
61 |
Cd3/cd19 negative hematopoietic stem cells |
- |
- |
- |
- |
085 [1] 85 💬 |
62 |
Cnc |
- |
- |
- |
- |
085 [1] 85 💬 |
63 |
Cnto 888 1 mg/kg |
- |
- |
- |
- |
085 [1] 85 💬 |
64 |
Cnto 888 15 mg/kg |
- |
- |
- |
- |
085 [1] 85 💬 |
65 |
Cnto 888 5 mg/kg |
- |
- |
- |
- |
085 [1] 85 💬 |
66 |
Cnto888 |
- |
- |
- |
- |
085 [1] 85 💬 |
67 |
Co |
- |
- |
- |
- |
006 [5] 6 , 13, 53, 70, 85 💬 |
68 |
Co-trimoxazole |
- |
- |
- |
- |
085 [1] 85 💬 |
69 |
Combined plasma exchange (pex), rituximab, and corticosteroids |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
085 [1] 85 💬 |
70 |
Compound 21 |
- |
- |
- |
- |
085 [1] 85 💬 |
71 |
Corticosteroid (prednisolone) |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
72 |
Cotrimoxazole |
- |
- |
- |
- |
085 [2] 85, 97 💬 |
73 |
Cravit |
- |
- |
- |
- |
085 [1] 85 💬 |
74 |
Cromoglicate |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
75 |
Cromoglicato disodico |
- |
- |
- |
- |
085 [1] 85 💬 |
76 |
Cromoglycate |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
77 |
Cromolyn |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
002 [3] 2 , 85, 98 💬 |
78 |
Cromolyn sodio (cromoglicato disodico, dscg) |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
79 |
Cromolyn sodium |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
80 |
Cromolyn sodium [disodium cromoglycate] |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
81 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
82 |
Cyclosphamine |
- |
- |
- |
- |
085 [1] 85 💬 |
83 |
Cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
006 [11] 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
84 |
Dabigatran |
Dabigatran |
[1] D09707 D09707 💬 |
F2 [1] F2 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
051 [4] 51, 85, 91, 124 💬 |
85 |
Dasatinib |
Dasatinib |
[2] D03658 D03658, D06414 D06414 💬 |
ABL1 [8] ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 |
Acute myeloid leukemia [74] Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
051 [2] 51, 85 💬 |
86 |
Dasatinib + quercetin |
Dasatinib |
[2] D03658 D03658, D06414 D06414 💬 |
ABL1 [8] ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 |
Acute myeloid leukemia [74] Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
085 [1] 85 💬 |
87 |
Device: auto-titrating oxygen system |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
88 |
Device: centricyte 1000 |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
89 |
Device: mri |
- |
- |
- |
- |
070 [3] 70, 85, 278 💬 |
90 |
Device: oxymizer® compared to cnc |
- |
- |
- |
- |
085 [1] 85 💬 |
91 |
Dex284 |
- |
- |
- |
- |
085 [1] 85 💬 |
92 |
Dextromethorphan |
Dextromethorphan |
[3] D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 [6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
93 |
Diagnostic test: metabolomics |
- |
- |
- |
- |
085 [1] 85 💬 |
94 |
Diagnostic test: pet imaging |
- |
- |
- |
- |
085 [1] 85 💬 |
95 |
Disodium cromoglycate (dscg) |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
96 |
Disodium cromoglycate [cromolyn sodium] |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
97 |
Doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 [15] 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
98 |
Dpa |
- |
- |
- |
- |
002 [4] 2 , 6 , 13, 85 💬 |
99 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 [9] 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
100 |
Endobronchial infusion of adult mesenchymal stem cells |
- |
- |
- |
- |
085 [1] 85 💬 |
101 |
Endoxan |
- |
- |
- |
- |
013 [7] 13, 28, 43, 44, 85, 96, 222 💬 |
102 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
008 [5] 8 , 13, 28, 85, 113 💬 |
103 |
Epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
028 [2] 28, 85 💬 |
104 |
Erivedge |
- |
- |
- |
- |
085 [1] 85 💬 |
105 |
Esbriet |
- |
- |
- |
- |
046 [4] 46, 51, 85, 228 💬 |
106 |
Esbriet® (pirfenidon) |
- |
- |
- |
- |
085 [1] 85 💬 |
107 |
Etanercept |
Etanercept |
[1] D00742 D00742 💬 |
LTA [2] LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
015 [14] 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬 |
108 |
Etoposide |
Etoposide |
[2] D00125 D00125, D04107 D04107 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
011 [11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
109 |
Ez-2053 |
- |
- |
- |
- |
085 [2] 85, 299 💬 |
110 |
Ez-2053 5mg/kg |
- |
- |
- |
- |
085 [2] 85, 299 💬 |
111 |
Fg-3019 |
- |
- |
- |
- |
085 [3] 85, 113, 222 💬 |
112 |
Fg-3019 10mg/ml in 10 ml vials |
- |
- |
- |
- |
085 [1] 85 💬 |
113 |
Fludarabine |
Fludarabine |
[2] D01907 D01907, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 [17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
114 |
Fludeoxyglucose |
Fludeoxyglucose |
[1] D01843 D01843 💬 |
- |
- |
034 [4] 34, 84, 85, 88 💬 |
115 |
Fluimucil |
- |
- |
- |
- |
085 [4] 85, 94, 193, 298 💬 |
116 |
Fluimucil® 600 mg effervescent tablets |
- |
- |
- |
- |
085 [1] 85 💬 |
117 |
Fluorine (18f) fludeoxyglucose |
Fludeoxyglucose |
[1] D01843 D01843 💬 |
- |
- |
084 [2] 84, 85 💬 |
118 |
Formoterol |
Formoterol |
[3] D01373 D01373, D05277 D05277, D07990 D07990 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
085 [3] 85, 228, 299 💬 |
119 |
Formoterol fumarate dihydrate |
Formoterol |
[3] D01373 D01373, D05277 D05277, D07990 D07990 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
120 |
Fostair |
- |
- |
- |
- |
085 [1] 85 💬 |
121 |
G-csf |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [16] 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
122 |
G321605 |
- |
- |
- |
- |
085 [3] 85, 96, 97 💬 |
123 |
G451990 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
124 |
Gallium68-dota-noc |
- |
- |
- |
- |
085 [1] 85 💬 |
125 |
Gbt440 |
- |
- |
- |
- |
085 [1] 85 💬 |
126 |
Gbt440 300 mg capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
127 |
Gbt440 300 mg tablet |
- |
- |
- |
- |
085 [1] 85 💬 |
128 |
Gc1008 |
Fresolimumab |
[1] D09620 D09620 💬 |
TGFB1 [3] TGFB1, TGFB2, TGFB3 💬 |
AGE-RAGE signaling pathway in diabetic complications [35] AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
085 [2] 85, 222 💬 |
129 |
Gefapixant |
Gefapixant |
[1] D11349 D11349 💬 |
P2RX3 [1] P2RX3 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Taste transduction |
085 [2] 85, 226 💬 |
130 |
Gkt137831 |
- |
- |
- |
- |
085 [2] 85, 93 💬 |
131 |
Glpg1205 |
- |
- |
- |
- |
085 [3] 85, 96, 97 💬 |
132 |
Glpg1690 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
133 |
Glpg1690 600 mg qd |
- |
- |
- |
- |
085 [1] 85 💬 |
134 |
Granulocyte colony stimulating factor |
Filgrastim |
[1] D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 [6] 2 , 28, 36, 57, 65, 85 💬 |
135 |
Gs-6624 |
Simtuzumab |
- |
- |
- |
085 [2] 85, 94 💬 |
136 |
Gsk2126458 |
- |
- |
- |
- |
085 [1] 85 💬 |
137 |
Gsk3008348 |
- |
- |
- |
- |
085 [1] 85 💬 |
138 |
Gsk3008348 nebuliser solution |
- |
- |
- |
- |
085 [1] 85 💬 |
139 |
Hec 68498 |
- |
- |
- |
- |
085 [1] 85 💬 |
140 |
Hec585 |
- |
- |
- |
- |
085 [1] 85 💬 |
141 |
High dose bibf 1120 twice daily |
- |
- |
- |
- |
085 [1] 85 💬 |
142 |
Humanized anti-alpha v beta 6 mab |
- |
- |
- |
- |
085 [1] 85 💬 |
143 |
Hydroxyurea |
Hydroxyurea |
[1] D00341 D00341 💬 |
RRM2 [1] RRM2 💬 |
Drug metabolism - other enzymes [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 [8] 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
144 |
Hyperoxia |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
145 |
Hyperpolarized 129 xenon gas comparing idiopathic pulmonary fibrosis (ipf) treatment |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
085 [1] 85 💬 |
146 |
Hyperpolarized 129-xenon gas |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
085 [1] 85 💬 |
147 |
Idl-2965 oral capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
148 |
Ifenprodil |
Ifenprodil |
[1] D08064 D08064 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
149 |
Iloprost |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [4] 51, 84, 85, 86 💬 |
150 |
Iloprost inhalation solution (ventavis) |
Iloprost |
[1] D02721 D02721 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
085 [2] 85, 86 💬 |
151 |
Imatinib |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
152 |
Imatinib mesylate (gleevec) |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
085 [1] 85 💬 |
153 |
Immukin |
- |
- |
- |
- |
085 [1] 85 💬 |
154 |
Inhaled carbon monoxide |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
085 [1] 85 💬 |
155 |
Inhaled nitric oxide |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
085 [2] 85, 86 💬 |
156 |
Inhaled nitric oxide - 30 mcg/kg ibw/hr |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
085 [1] 85 💬 |
157 |
Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
085 [1] 85 💬 |
158 |
Inhaled nitric oxide 75 mcg/kg ibw/hr |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
085 [2] 85, 86 💬 |
159 |
Inhaled td139 |
- |
- |
- |
- |
085 [1] 85 💬 |
160 |
Ino |
- |
- |
- |
- |
085 [2] 85, 86 💬 |
161 |
Inomax |
- |
- |
- |
- |
085 [3] 85, 294, 299 💬 |
162 |
Inomax 400ppm mol/mol inhalation gas |
- |
- |
- |
- |
085 [2] 85, 299 💬 |
163 |
Interferon alpha oral lozenge |
- |
- |
- |
- |
085 [1] 85 💬 |
164 |
Interferon gamma |
Interferon Gamma |
- |
- |
- |
018 [8] 18, 65, 85, 107, 228, 299, 301, 326 💬 |
165 |
Interferon gamma-1b |
Interferon Gamma |
[1] D00747 D00747 💬 |
IFNGR1 [2] IFNGR1, IFNGR2 💬 |
Chagas disease [18] Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
018 [7] 18, 65, 85, 228, 299, 301, 326 💬 |
166 |
Interferon gamma-1b (actimmune) |
Interferon Gamma |
[1] D00747 D00747 💬 |
IFNGR1 [2] IFNGR1, IFNGR2 💬 |
Chagas disease [18] Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
085 [1] 85 💬 |
167 |
Interferon-alpha lozenges |
- |
- |
- |
- |
085 [1] 85 💬 |
168 |
Interferon-gamma 1b |
- |
- |
- |
- |
085 [1] 85 💬 |
169 |
Intermediate dose bibf 1120 twice daily |
- |
- |
- |
- |
085 [1] 85 💬 |
170 |
Iw001 |
- |
- |
- |
- |
085 [1] 85 💬 |
171 |
Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
085 [1] 85 💬 |
172 |
Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
085 [1] 85 💬 |
173 |
Jin-shui huan-xian granule |
- |
- |
- |
- |
085 [1] 85 💬 |
174 |
Kd025 |
- |
- |
- |
- |
085 [1] 85 💬 |
175 |
L - antineoplastic and immunomodulating agents |
- |
- |
- |
- |
085 [1] 85 💬 |
176 |
L01 - antineoplastic agents |
- |
- |
- |
- |
085 [1] 85 💬 |
177 |
L01x - other antineoplastic agents |
- |
- |
- |
- |
085 [1] 85 💬 |
178 |
L01xe - protein kinase inhibitors |
- |
- |
- |
- |
085 [1] 85 💬 |
179 |
L01xe31 |
- |
- |
- |
- |
085 [1] 85 💬 |
180 |
L01xe31 - nintedanib |
Nintedanib |
[1] D10481 D10481 💬 |
FGFR1 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction [34] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
085 [1] 85 💬 |
181 |
Lanreotide |
Lanreotide |
[1] D04666 D04666 💬 |
- |
- |
067 [4] 67, 73, 85, 298 💬 |
182 |
Lanreotide acetate |
Acetate |
[1] D04666 D04666 💬 |
- |
- |
067 [4] 67, 73, 85, 298 💬 |
183 |
Lansoprazole |
Lansoprazole |
[1] D00355 D00355 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 [7] 63, 71, 85, 98, 166, 222, 299 💬 |
184 |
Lebrikizumab |
Lebrikizumab |
[1] D09633 D09633 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [1] 85 💬 |
185 |
Letairis |
- |
- |
- |
- |
085 [1] 85 💬 |
186 |
Letairis 10 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
187 |
Letairis 5 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
188 |
Liberase enzyme (roche) |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
189 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
190 |
Low dose bibf 1120 twice daily |
- |
- |
- |
- |
085 [1] 85 💬 |
191 |
Low dose bibf1120 once daily |
- |
- |
- |
- |
085 [1] 85 💬 |
192 |
Lpa1 |
- |
- |
- |
- |
085 [1] 85 💬 |
193 |
Lung spheroid stem cells 100 million |
- |
- |
- |
- |
085 [1] 85 💬 |
194 |
Lung spheroid stem cells 200 million |
- |
- |
- |
- |
085 [1] 85 💬 |
195 |
Lung stem cells |
- |
- |
- |
- |
085 [1] 85 💬 |
196 |
Macitentan |
Macitentan |
[1] D10135 D10135 💬 |
EDNRA [2] EDNRA, EDNRB 💬 |
Calcium signaling pathway [9] Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [5] 51, 85, 86, 88, 210 💬 |
197 |
Medical air |
Medical air |
- |
- |
- |
085 [3] 85, 86, 193 💬 |
198 |
Medical air (sham o2) |
Medical air |
- |
- |
- |
085 [1] 85 💬 |
199 |
Mesna |
- |
- |
- |
- |
011 [11] 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
200 |
Mg-s-2525 |
- |
- |
- |
- |
085 [1] 85 💬 |
201 |
Minocycline |
Minocycline |
[2] D00850 D00850, D05045 D05045 💬 |
- |
- |
002 [13] 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
202 |
Monitor |
Methamidophos |
- |
- |
- |
002 [18] 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
203 |
Montelukast |
Montelukast |
[2] D00529 D00529, D08229 D08229 💬 |
CYSLTR1 [1] CYSLTR1 💬 |
Calcium signaling pathway [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction |
013 [5] 13, 46, 85, 98, 228 💬 |
204 |
Morphine |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 [5] 36, 46, 70, 85, 86 💬 |
205 |
Morphine hydrochloride |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
206 |
Morphine sulfate |
Morphine |
[3] D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 [1] OPRM1 💬 |
Estrogen signaling pathway [3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 [3] 46, 85, 86 💬 |
207 |
Moxifloxacin |
Moxifloxacin |
[2] D00874 D00874, D08237 D08237 💬 |
- |
- |
002 [8] 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
208 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
209 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
210 |
N-acetyl cysteine |
Cysteine |
[2] D00026 D00026, D02326 D02326 💬 |
- |
- |
013 [7] 13, 19, 34, 85, 88, 296, 310 💬 |
211 |
N-acetylcysteine |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [10] 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
212 |
N-acetylcysteine, (nac) |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
085 [1] 85 💬 |
213 |
Na |
- |
- |
- |
- |
036 [3] 36, 46, 85 💬 |
214 |
Nac |
- |
- |
- |
- |
034 [5] 34, 51, 85, 90, 299 💬 |
215 |
Nalbuphine |
Nalbuphine |
[2] D00843 D00843, D08246 D08246 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
216 |
Nalbuphine er |
Nalbuphine |
[2] D00843 D00843, D08246 D08246 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
217 |
Nalbuphine extended-realease (er) tablets |
Nalbuphine |
[2] D00843 D00843, D08246 D08246 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
218 |
Nalbuphine extended-release (er) tablets |
Nalbuphine |
[2] D00843 D00843, D08246 D08246 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
219 |
Nalbuphine hydrochloride |
Nalbuphine |
[2] D00843 D00843, D08246 D08246 💬 |
OPRD1 [3] OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway [5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
220 |
Nandrolone |
Nandrolone |
[1] D08250 D08250 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
060 [2] 60, 85 💬 |
221 |
Nandrolone decanoate |
Nandrolone |
[2] D00955 D00955, D08250 D08250 💬 |
AR [1] AR 💬 |
Oocyte meiosis [3] Oocyte meiosis, Pathways in cancer, Prostate cancer |
060 [2] 60, 85 💬 |
222 |
Nd-l02-s0201 |
- |
- |
- |
- |
085 [1] 85 💬 |
223 |
Nd-l02-s0201 for injection |
- |
- |
- |
- |
085 [1] 85 💬 |
224 |
Nintedanib |
Nintedanib |
[1] D10481 D10481 💬 |
FGFR1 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction [34] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
051 [5] 51, 85, 89, 227, 228 💬 |
225 |
Nitric oxide |
Nitric Oxide |
[1] D00074 D00074 💬 |
- |
- |
046 [8] 46, 85, 86, 98, 210, 251, 294, 299 💬 |
226 |
Nivolumab |
Nivolumab |
[1] D10316 D10316 💬 |
PDCD1 [1] PDCD1 💬 |
Cell adhesion molecules [3] Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
227 |
None |
- |
- |
- |
- |
046 [14] 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
228 |
Octreotide |
Octreotide |
[2] D00442 D00442, D06495 D06495 💬 |
SSTR2 [1] SSTR2 💬 |
Gastric acid secretion [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 [7] 67, 75, 84, 85, 89, 193, 227 💬 |
229 |
Ofev |
- |
- |
- |
- |
051 [5] 51, 85, 89, 227, 228 💬 |
230 |
Ofev 100 mg capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
231 |
Ofev 150 mg capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
232 |
Ofev® |
- |
- |
- |
- |
085 [1] 85 💬 |
233 |
Omeprazole |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
234 |
Omeprazole (uk licensed generic product) |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
085 [1] 85 💬 |
235 |
Orin1001 |
- |
- |
- |
- |
085 [1] 85 💬 |
236 |
Other: 60% oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
237 |
Other: control |
- |
- |
- |
- |
006 [8] 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
238 |
Other: cough monitor |
Methamidophos |
- |
- |
- |
085 [1] 85 💬 |
239 |
Other: medical air |
Medical air |
- |
- |
- |
085 [1] 85 💬 |
240 |
Other: no intervention: standard of care |
- |
- |
- |
- |
085 [1] 85 💬 |
241 |
Other: oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
242 |
Other: oxygen (2liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
243 |
Other: oxygen (4liter/min) |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
244 |
Other: pulmonary rehabilitation program |
- |
- |
- |
- |
085 [1] 85 💬 |
245 |
Other: standard of care |
- |
- |
- |
- |
013 [7] 13, 49, 64, 85, 96, 245, 246 💬 |
246 |
Other: untreated cohort |
- |
- |
- |
- |
085 [1] 85 💬 |
247 |
Oxygen |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
006 [18] 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
248 |
Oxygen 40 % |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
085 [1] 85 💬 |
249 |
Pa101 |
- |
- |
- |
- |
085 [1] 85 💬 |
250 |
Paclitaxel |
Paclitaxel |
[2] D00491 D00491, D05333 D05333 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
046 [2] 46, 85 💬 |
251 |
Pamrevlumab |
Pamrevlumab |
[1] D10969 D10969 💬 |
CCN2 [1] CCN2 💬 |
Apelin signaling pathway [2] Apelin signaling pathway, Hippo signaling pathway |
085 [2] 85, 113 💬 |
252 |
Pbi4050 |
- |
- |
- |
- |
085 [2] 85, 299 💬 |
253 |
Pd00377 na-salt |
- |
- |
- |
- |
085 [1] 85 💬 |
254 |
Pet/ct using pet ligands [f-18]fdg and [f-18]dpa-714 |
- |
- |
- |
- |
085 [1] 85 💬 |
255 |
Pir, s-7701 |
- |
- |
- |
- |
085 [1] 85 💬 |
256 |
Pirfenidone |
Pirfenidone |
[1] D01583 D01583 💬 |
CCL2 [6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [82] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
257 |
Pirfenidone and nintedanib |
Nintedanib |
[2] D01583 D01583, D10481 D10481 💬 |
CCL2 [14] CCL2, FGFR1, FGFR2, FGFR3, FLT1, FLT4, IL10, IL1A, IL1B, IL6, KDR, PDGFRA, PDGFRB, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [104] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [1] 85 💬 |
258 |
Pirfenidone or nintedanib |
Nintedanib |
[2] D01583 D01583, D10481 D10481 💬 |
CCL2 [14] CCL2, FGFR1, FGFR2, FGFR3, FLT1, FLT4, IL10, IL1A, IL1B, IL6, KDR, PDGFRA, PDGFRB, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [104] AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [1] 85 💬 |
259 |
Pirfenidoneone |
- |
- |
- |
- |
085 [1] 85 💬 |
260 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
261 |
Pln-74809 |
- |
- |
- |
- |
085 [2] 85, 94 💬 |
262 |
Pln-74809-000 |
- |
- |
- |
- |
085 [1] 85 💬 |
263 |
Pomalidomide |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 [6] 28, 34, 51, 85, 227, 331 💬 |
264 |
Pomalidomide (cc-4047 |
Pomalidomide |
[1] D08976 D08976 💬 |
IL6 [2] IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [78] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [1] 85 💬 |
265 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
266 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
267 |
Privigen 100mg/ml |
- |
- |
- |
- |
085 [1] 85 💬 |
268 |
Prm-151 |
PRM-151 |
- |
- |
- |
085 [1] 85 💬 |
269 |
Procedure: iv deployment of csvf in sterile normal saline iv solution |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
270 |
Procedure: microcannula harvest adipose derived tissue stromal vascular fraction (tsvf) |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
271 |
Pzn 8881655(rochepharma ag) |
- |
- |
- |
- |
085 [1] 85 💬 |
272 |
Qax576 |
- |
- |
- |
- |
051 [4] 51, 85, 96, 98 💬 |
273 |
Quercetin |
Quercetin |
- |
- |
- |
084 [5] 84, 85, 192, 285, 299 💬 |
274 |
Radiation: fdg pet scan |
- |
- |
- |
- |
085 [1] 85 💬 |
275 |
Radiation: gsk26346763: ([18f]-fba-a20fmdv2) iv infusion |
- |
- |
- |
- |
085 [1] 85 💬 |
276 |
Radiation: knottin tracer |
- |
- |
- |
- |
085 [1] 85 💬 |
277 |
Remicade |
- |
- |
- |
- |
040 [9] 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
278 |
Revatio |
- |
- |
- |
- |
085 [3] 85, 86, 113 💬 |
279 |
Revatio 20 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
280 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
281 |
Rixathon 500 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
282 |
Ro 47-0203 |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
283 |
Ro0220912 |
- |
- |
- |
- |
085 [1] 85 💬 |
284 |
Ro0280296 |
- |
- |
- |
- |
085 [1] 85 💬 |
285 |
Ro5490255 |
- |
- |
- |
- |
085 [1] 85 💬 |
286 |
Ro5490255/f01-02 |
- |
- |
- |
- |
085 [1] 85 💬 |
287 |
Rvt-1601 |
- |
- |
- |
- |
085 [1] 85 💬 |
288 |
Rvt-1601 (formerly, pa101b) |
- |
- |
- |
- |
085 [1] 85 💬 |
289 |
Salbutamol |
Salbutamol |
[1] D02147 D02147 💬 |
ADRB2 [1] ADRB2 💬 |
Adrenergic signaling in cardiomyocytes [8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 [9] 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
290 |
Sar156597 |
- |
- |
- |
- |
051 [2] 51, 85 💬 |
291 |
Saracatinab |
- |
- |
- |
- |
085 [1] 85 💬 |
292 |
Septrin |
- |
- |
- |
- |
085 [1] 85 💬 |
293 |
Sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 [17] 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
294 |
Sildenafil (50 mg) |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
295 |
Sildenafil and losartan |
Losartan |
[4] D00357 D00357, D02229 D02229, D08146 D08146, D08514 D08514 💬 |
AGTR1 [2] AGTR1, PDE5A 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 [1] 85 💬 |
296 |
Sildenafil citrate |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 [4] 51, 85, 86, 225 💬 |
297 |
Simtuzumab |
Simtuzumab |
- |
- |
- |
085 [2] 85, 94 💬 |
298 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
299 |
Sivelestat |
Sivelestat |
[1] D03788 D03788 💬 |
ELANE [1] ELANE 💬 |
Neutrophil extracellular trap formation [3] Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer |
013 [3] 13, 85, 96 💬 |
300 |
Sm04646 |
- |
- |
- |
- |
085 [1] 85 💬 |
301 |
Sodium cromoglicate |
Cromoglicic acid |
[2] D00526 D00526, D07753 D07753 💬 |
- |
- |
085 [1] 85 💬 |
302 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
303 |
Standard steroid treatment |
- |
- |
- |
- |
085 [1] 85 💬 |
304 |
Sterile normal saline for intravenous use |
- |
- |
- |
- |
085 [2] 85, 229 💬 |
305 |
Sub-study: nintedanib |
Nintedanib |
[1] D10481 D10481 💬 |
FGFR1 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction [34] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
085 [1] 85 💬 |
306 |
Sub-study: pirfenidone |
Pirfenidone |
[1] D01583 D01583 💬 |
CCL2 [6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [82] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [1] 85 💬 |
307 |
Sulfamethoxazole |
Sulfamethoxazole |
[1] D00447 D00447 💬 |
- |
- |
044 [4] 44, 49, 85, 299 💬 |
308 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
309 |
Sulphamethoxazole |
Sulfamethoxazole |
[1] D00447 D00447 💬 |
- |
- |
085 [1] 85 💬 |
310 |
Symbicort |
- |
- |
- |
- |
085 [2] 85, 228 💬 |
311 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
312 |
Tbc |
- |
- |
- |
- |
085 [3] 85, 94, 96 💬 |
313 |
Td-1058 |
- |
- |
- |
- |
085 [1] 85 💬 |
314 |
Td139 |
- |
- |
- |
- |
085 [1] 85 💬 |
315 |
Tetrandrine |
Tetrandrine |
- |
- |
- |
046 [2] 46, 85 💬 |
316 |
Tetrathiomolybdate |
Tetrathiomolybdate |
- |
- |
- |
085 [3] 85, 93, 171 💬 |
317 |
Thalidomide |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 [20] 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
318 |
Thalidomide pharmion |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 [3] 85, 96, 97 💬 |
319 |
The standard steroid treatment, plasma exchange and rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
085 [1] 85 💬 |
320 |
Thiotepa |
Thiotepa |
[1] D00583 D00583 💬 |
- |
- |
013 [11] 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
321 |
Thrombomodulin alfa |
Thrombomodulin Alfa |
[1] D06410 D06410 💬 |
F2 [1] F2 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
085 [1] 85 💬 |
322 |
Tiotropium |
Tiotropium |
- |
- |
- |
055 [3] 55, 85, 299 💬 |
323 |
Tipelukast |
Tipelukast |
[1] D06659 D06659 💬 |
CYSLTR1 [1] CYSLTR1 💬 |
Calcium signaling pathway [2] Calcium signaling pathway, Neuroactive ligand-receptor interaction |
085 [1] 85 💬 |
324 |
Tnx-650, rhumab anti-il13, ail-13, milr1444a |
- |
- |
- |
- |
085 [1] 85 💬 |
325 |
Tr0311 |
- |
- |
- |
- |
085 [1] 85 💬 |
326 |
Tracleer |
- |
- |
- |
- |
013 [8] 13, 51, 84, 85, 86, 88, 210, 211 💬 |
327 |
Traditional chinese medicine formulation |
- |
- |
- |
- |
085 [1] 85 💬 |
328 |
Tralokinumab |
Tralokinumab |
[1] D09979 D09979 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [2] 85, 97 💬 |
329 |
Tralokinumab cohort 1 |
Tralokinumab |
[1] D09979 D09979 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [1] 85 💬 |
330 |
Tralokinumab cohort 2 |
Tralokinumab |
[1] D09979 D09979 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [1] 85 💬 |
331 |
Tralokinumab is a human recombinant monoclonal antibody (mab) of the subclass that specifically binds human il-13, blocking interactions with the il-13 receptor |
Tralokinumab |
[1] D09979 D09979 💬 |
IL13 [1] IL13 💬 |
Asthma [8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 [1] 85 💬 |
332 |
Treatment as usual (tau) |
- |
- |
- |
- |
085 [1] 85 💬 |
333 |
Treprostinil |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 [6] 51, 84, 85, 86, 88, 210 💬 |
334 |
Treprostinil sodium for inhalation |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
085 [1] 85 💬 |
335 |
Trimethoprim |
Trimethoprim |
[2] D00145 D00145, D06236 D06236 💬 |
- |
- |
036 [6] 36, 44, 49, 60, 85, 299 💬 |
336 |
Trk-250 |
- |
- |
- |
- |
085 [1] 85 💬 |
337 |
Uromitexan |
- |
- |
- |
- |
085 [1] 85 💬 |
338 |
Valganciclovir |
Valganciclovir |
[1] D02495 D02495 💬 |
- |
- |
028 [6] 28, 60, 85, 97, 299, 331 💬 |
339 |
Vasoactive intestinal peptide |
- |
- |
- |
- |
085 [1] 85 💬 |
340 |
Vay736 |
- |
- |
- |
- |
013 [7] 13, 35, 46, 49, 53, 85, 95 💬 |
341 |
Vismodegib |
Vismodegib |
[1] D09992 D09992 💬 |
SMO [1] SMO 💬 |
Axon guidance [5] Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer |
085 [1] 85 💬 |
342 |
Volibris |
- |
- |
- |
- |
051 [4] 51, 85, 86, 88 💬 |
343 |
Vrp700 |
- |
- |
- |
- |
085 [1] 85 💬 |
344 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
345 |
Xenon |
Xenon |
[2] D01901 D01901, D06339 D06339 💬 |
- |
- |
022 [4] 22, 85, 228, 299 💬 |
346 |
Zileuton |
Zileuton |
[1] D00414 D00414 💬 |
ALOX5 [1] ALOX5 💬 |
Arachidonic acid metabolism [6] Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis |
085 [3] 85, 160, 164 💬 |
347 |
Ziritaxestat |
Ziritaxestat |
[1] D11844 D11844 💬 |
ENPP2 [1] ENPP2 💬 |
Ether lipid metabolism [1] Ether lipid metabolism |
051 [2] 51, 85 💬 |
348 |
Zl-2102 |
- |
- |
- |
- |
085 [1] 85 💬 |
349 |
Zsp1603 12.5 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
350 |
Zsp1603 25 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
351 |
Zsp1603 50 mg |
- |
- |
- |
- |
085 [1] 85 💬 |
352 |
Zsp1603 7.5 mg |
- |
- |
- |
- |
085 [1] 85 💬 |